Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
This guide compares risk levels between bonds and stocks in retirement, outlining factors like market cycles, duration, and income needs.
28,346 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Saving in a bank account isn’t just putting money somewhere safe. It’s about building resilience for emergencies, fun...
Circle Ventures leads Tazapay’s Series B extension to $36M, backing rapid expansion of licensing and market entry in ...
A Brixton bank branch faced a bold scam when a man wore an old G4S uniform to obtain cash. This is how the asked cash...
A landmark innovator, Ted Turner reshaped TV by launching CNN, expanding cable, and preserving Hollywood classics. Th...
The SEC is poised to publish three crypto rulemaking proposals in July, potentially beginning formal regulation befor...
Super Micro Computer beat expectations on adjusted earnings and guided higher for Q4 revenue, while unveiling a nucle...
A Frontier Airlines flight aborted takeoff at DEN after a pedestrian jumped Denver airport perimeter, prompting an en...
Solana has risen about 4.5% over the past week as the Alpenglow upgrade advances in validator testing, stoking bets o...
Public trading disclosures show a sharp spike in activity by the former president, with Trump’s trading volume just s...
In a year of AI-driven consolidation, three enterprise software names are walling off attention as potential takeout ...
Kinross Gold posted a solid Q4 print after the bell, beating expectations with $0.67 in adjusted EPS and outlining 20...